What is Clinical Laserthermia Systems AB Gross Margin %?
Clinical Laserthermia Systems ABFRA:LS60 -2.91%36 Gross Margin % is 60.17% as of Mar. 2026, which is 66% above its 10-year median of 36.23. GuruFocus rates FRA:LS60 with a GF Score™ of 36/100 and a GF Value™ of €0.29 (Fairly Valued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Clinical Laserthermia Systems AB ranks better than 64.84% on this metric.
FRA:LS60's Gross Margin % is ranked better than 64.84% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs FRA:LS60: 61.72
Clinical Laserthermia Systems AB had a gross margin of 60.17% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Clinical Laserthermia Systems AB (FRA:LS60) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Clinical Laserthermia Systems AB had a gross margin of 60.17% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Clinical Laserthermia Systems AB Gross Margin % Related Terms
Clinical Laserthermia Systems AB Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinical Laserthermia Systems AB Gross Margin % Chart
FRA:LS60 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Clinical Laserthermia Systems AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinical Laserthermia Systems AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Clinical Laserthermia Systems AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Clinical Laserthermia Systems AB (FRA:LS60) has a Gross Margin % of 60.17% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Clinical Laserthermia Systems AB and its competitors. This is 66% above median its historical median of 36.23. According to the industry distribution chart, Clinical Laserthermia Systems AB ranks #283 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 35.2%.
Is Clinical Laserthermia Systems AB's Gross Margin % too high?
Clinical Laserthermia Systems AB's current Gross Margin % of 60.17% is 66% above median its 10-year median of 36.23. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Clinical Laserthermia Systems AB's value of 60.17% is 15.6% above this industry median. Based on the distribution chart, Clinical Laserthermia Systems AB ranks #283 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Clinical Laserthermia Systems AB has a GF Score™ of 36/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Clinical Laserthermia Systems AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Clinical Laserthermia Systems AB ranks #283 out of 805 companies for Gross Margin %. This puts Clinical Laserthermia Systems AB in the upper half of its industry. The industry median Gross Margin % is 52.07. Clinical Laserthermia Systems AB's value of 60.17% is 15.6% above this benchmark. While the company's 10-year median is 36.23 vs. the industry median of 52.07, Clinical Laserthermia Systems AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clinical Laserthermia Systems AB's current Gross Margin % of 60.17% is 15.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Clinical Laserthermia Systems AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinical Laserthermia Systems AB's current Gross Margin % is 60.17%, which is 66% above median its own 10-year median of 36.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinical Laserthermia Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB (FRA:LS60) is currently considered Fairly Valued. The stock's GF Value™ is €0.29, compared to a current price of €0.27 — trading 7.9% below its estimated fair value. The current Gross Margin % is 60.17%, which is 66% above median its 10-year median of 36.23 and 15.6% above the Medical Devices & Instruments industry median of 52.07. Clinical Laserthermia Systems AB's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Clinical Laserthermia Systems AB (FRA:LS60), the current Gross Margin % is 60.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued.
The current stock price of €0.27 is trading 7.9% below its estimated GF Value™ of €0.29.
GuruFocus considers Clinical Laserthermia Systems AB to be Fairly Valued.
Key valuation signals for FRA:LS60:
Gross Margin %: 60.17% (66% above median its 10-year median of 36.23)
GF Value™: €0.29 vs. price of €0.27 (7.9% below fair value)
Industry Position: 15.6% above the Medical Devices & Instruments median (#283 of 805)
No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clinical Laserthermia Systems AB Business Description
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
36GF Score
Get the complete analysis for FRA:LS60
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LS60 has been successfully added to your 
